Literature DB >> 22843992

Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer.

Chun-I Wang1, Kun-Yi Chien, Chih-Liang Wang, Hao-Ping Liu, Chia-Chen Cheng, Yu-Sun Chang, Jau-Song Yu, Chia-Jung Yu.   

Abstract

The process of nucleocytoplasmic shuttling is mediated by karyopherins. Dysregulated expression of karyopherins may trigger oncogenesis through aberrant distribution of cargo proteins. Karyopherin subunit alpha-2 (KPNA2) was previously identified as a potential biomarker for nonsmall cell lung cancer by integration of the cancer cell secretome and tissue transcriptome data sets. Knockdown of KPNA2 suppressed the proliferation and migration abilities of lung cancer cells. However, the precise molecular mechanisms underlying KPNA2 activity in cancer remain to be established. In the current study, we applied gene knockdown, subcellular fractionation, and stable isotope labeling by amino acids in cell culture-based quantitative proteomic strategies to systematically analyze the KPNA2-regulating protein profiles in an adenocarcinoma cell line. Interaction network analysis revealed that several KPNA2-regulating proteins are involved in the cell cycle, DNA metabolic process, cellular component movements and cell migration. Importantly, E2F1 was identified as a potential novel cargo of KPNA2 in the nuclear proteome. The mRNA levels of potential effectors of E2F1 measured using quantitative PCR indicated that E2F1 is one of the "master molecule" responses to KPNA2 knockdown. Immunofluorescence staining and immunoprecipitation assays disclosed co-localization and association between E2F1 and KPNA2. An in vitro protein binding assay further demonstrated that E2F1 interacts directly with KPNA2. Moreover, knockdown of KPNA2 led to subcellular redistribution of E2F1 in lung cancer cells. Our results collectively demonstrate the utility of quantitative proteomic approaches and provide a fundamental platform to further explore the biological roles of KPNA2 in nonsmall cell lung cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22843992      PMCID: PMC3494185          DOI: 10.1074/mcp.M111.016592

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  89 in total

1.  Amino acid residue specific stable isotope labeling for quantitative proteomics.

Authors:  Haining Zhu; Songqin Pan; Sheng Gu; E Morton Bradbury; Xian Chen
Journal:  Rapid Commun Mass Spectrom       Date:  2002       Impact factor: 2.419

2.  Significance of karyopherin-{alpha} 2 (KPNA2) expression in esophageal squamous cell carcinoma.

Authors:  Makoto Sakai; Makoto Sohda; Tatsuya Miyazaki; Shigemasa Suzuki; Akihiko Sano; Naritaka Tanaka; Takanori Inose; Masanobu Nakajima; Hiroyuki Kato; Hiroyuki Kuwano
Journal:  Anticancer Res       Date:  2010-03       Impact factor: 2.480

3.  Distinct roles for classical nuclear import receptors in the growth of multinucleated muscle cells.

Authors:  Monica N Hall; Christine A Griffin; Adriana Simionescu; Anita H Corbett; Grace K Pavlath
Journal:  Dev Biol       Date:  2011-06-30       Impact factor: 3.582

4.  Identification of a novel cytoplasmic protein that specifically binds to nuclear localization signal motifs.

Authors:  S Li; C Y Ku; A A Farmer; Y S Cong; C F Chen; W H Lee
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

5.  Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro.

Authors:  E Noetzel; M Rose; J Bornemann; M Gajewski; R Knüchel; E Dahl
Journal:  Oncogene       Date:  2011-09-12       Impact factor: 9.867

6.  Regulation of nuclear localization signal-importin α interaction by Ca2+/S100A6.

Authors:  Maki Takata; Seiko Shimamoto; Fuminori Yamaguchi; Masaaki Tokuda; Hiroshi Tokumitsu; Ryoji Kobayashi
Journal:  FEBS Lett       Date:  2010-10-21       Impact factor: 4.124

7.  High expression of karyopherin-α2 defines poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomy.

Authors:  Jørgen Bjerggaard Jensen; Pia Pinholt Munksgaard; Christoffer Mørk Sørensen; Niels Fristrup; Karin Birkenkamp-Demtroder; Benedicte Parm Ulhøi; Klaus Møller-Ernst Jensen; Torben F Ørntoft; Lars Dyrskjøt
Journal:  Eur Urol       Date:  2011-02-16       Impact factor: 20.096

8.  Regulation of vascular endothelial growth factor receptors by Rb and E2F1: role of acetylation.

Authors:  Smitha Pillai; Michelle Kovacs; Srikumar Chellappan
Journal:  Cancer Res       Date:  2010-06-01       Impact factor: 12.701

9.  Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt.

Authors:  Yen-Chung Chen; Yi-Ning Su; Po-Chien Chou; Wei-Chung Chiang; Ming-Cheng Chang; Liang-Shun Wang; Shu-Chun Teng; Kou-Juey Wu
Journal:  J Biol Chem       Date:  2005-07-21       Impact factor: 5.157

Review 10.  Classical nuclear localization signals: definition, function, and interaction with importin alpha.

Authors:  Allison Lange; Ryan E Mills; Christopher J Lange; Murray Stewart; Scott E Devine; Anita H Corbett
Journal:  J Biol Chem       Date:  2006-12-14       Impact factor: 5.157

View more
  37 in total

1.  Identification and Characterization of Potential Biomarkers by Quantitative Tissue Proteomics of Primary Lung Adenocarcinoma.

Authors:  Chiung-Hung Hsu; Chia-Wei Hsu; Chuen Hsueh; Chih-Liang Wang; Yi-Cheng Wu; Chih-Ching Wu; Chin-Ching Liu; Jau-Song Yu; Yu-Sun Chang; Chia-Jung Yu
Journal:  Mol Cell Proteomics       Date:  2016-05-09       Impact factor: 5.911

2.  Analytic P-value calculation for the higher criticism test in finite d problems.

Authors:  Ian J Barnett; Xihong Lin
Journal:  Biometrika       Date:  2014       Impact factor: 2.445

3.  Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer.

Authors:  Dongjun Jeong; Hyeongjoo Kim; Seona Ban; Seunghyun Oh; Sanghee Ji; Doyeon Kim; Tae Sung Ahn; Han Jo Kim; Sang Byung Bae; Hyog Young Kwon; Jungkyun Im; Moon Soo Lee; Hyun Deuk Cho; Chang-Jin Kim; Moo-Jun Baek
Journal:  J Cancer Res Clin Oncol       Date:  2017-09-05       Impact factor: 4.553

4.  Aberrant expression of nuclear KPNA2 is correlated with early recurrence and poor prognosis in patients with small hepatocellular carcinoma after hepatectomy.

Authors:  Peng Jiang; Yunqiang Tang; Lu He; Hui Tang; Min Liang; Cong Mai; Lijuan Hu; Jian Hong
Journal:  Med Oncol       Date:  2014-07-17       Impact factor: 3.064

5.  Zika virus NS2A protein induces the degradation of KPNA2 (karyopherin subunit alpha 2) via chaperone-mediated autophagy.

Authors:  Jia He; Liping Yang; Peixi Chang; Shixing Yang; Shaoli Lin; Qiyi Tang; Xinping Wang; Yan-Jin Zhang
Journal:  Autophagy       Date:  2020-09-28       Impact factor: 16.016

6.  Low cytoplasmic and nuclear KPNA2 expression in radiotherapy-treated head and neck squamous cell cancer is associated with an adverse outcome.

Authors:  Pia B Erben; Kathrin Brunner; Markus Hecht; Marlen Haderlein; Maike Büttner-Herold; Abbas Agaimy; Rainer Fietkau; Arndt Hartmann; Luitpold V Distel
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

Review 7.  Karyopherins in cancer.

Authors:  Tolga Çağatay; Yuh Min Chook
Journal:  Curr Opin Cell Biol       Date:  2018-02-04       Impact factor: 8.382

8.  Identification of cargo proteins specific for importin-β with importin-α applying a stable isotope labeling by amino acids in cell culture (SILAC)-based in vitro transport system.

Authors:  Makoto Kimura; Nobuaki Okumura; Shingo Kose; Toshifumi Takao; Naoko Imamoto
Journal:  J Biol Chem       Date:  2013-07-11       Impact factor: 5.157

9.  MIR517C inhibits autophagy and the epithelial-to-mesenchymal (-like) transition phenotype in human glioblastoma through KPNA2-dependent disruption of TP53 nuclear translocation.

Authors:  Yuntao Lu; Limin Xiao; Yawei Liu; Hai Wang; Hong Li; Qiang Zhou; Jun Pan; Bingxi Lei; Annie Huang; Songtao Qi
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

Review 10.  Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture.

Authors:  Debasish Paul; Avinash Kumar; Akshada Gajbhiye; Manas K Santra; Rapole Srikanth
Journal:  Biomed Res Int       Date:  2013-03-17       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.